Urgent.News

What's breaking now, across thousands of outlets.

Business

German-French agreement on "Made in Europe" and car exhaust gases delayed - SPD raises objections

The draft agreement provides for stricter admission conditions for non-EU countries with regard to participation in public tenders and the use of public funding, and moderates the ban on combustion engines from 2035.

Translated from German Read in German

France and Germany have failed to reach a common stance on the scope of the EU's future "Made in Europe" rules and on greater flexibility in reducing CO2 emissions and banning combustion engines by 2035. The two countries had been close to an agreement, with Germany set to accept stricter "Made in Europe" criteria for the automotive sector in exchange for a watering down of the combustion engine ban.

However, the deal was put on hold after Germany's coalition partner SPD raised concerns that key environmental targets would be dropped. A final agreement is still pending, with French President Emmanuel Macron saying earlier this week that it was now Germany's turn to make a move.

Written by urgent.news from Politico EU's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.

Read the original at politico.eu →

More in Business

Lenovo and HKC monitors achieve TÜV Rheinland gaming certification

Technology vendors Lenovo and HKC earned TÜV Rheinland Native Gaming Performance Certification across 20 display models following performance and human factor evaluation testing

  • Lenovo Legion series and HKC ANTGAMER monitors certified by TÜV Rheinland.
  • Certification evaluates native, overclocked, and dual-mode refresh rates.
  • Four Lenovo and four ANTGAMER models achieve 5-Star rating.

Brii Biosciences introduces BRiSC platform for dual targeting siRNA drugs

Biotechnology company Brii Biosciences launched its proprietary BRiSC discovery platform to accelerate development of next generation dual targeting small interfering RNA therapeutic candidates

  • Brii Biosciences introduces BRiSC platform for dual targeting siRNA drugs.
  • BRiSC combines four technologies for optimizing RNA-based therapies.
  • Dual-targeting architecture suppresses two targets with single siRNA.

More from Friday 16 October →